|
|
Gilead Sciences Inc CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization264,751 mln
Float8,254 mln
Earnings Date10/22/2026
Pre-Tax Margin
-6%
Marginally loss-making
Key Fundamentals
EPS-0.54
ROE-16.32
ROIC26.41
ROA-5.81
Interest Cover11.95
EBITDA, mln2,419
EV / EBITDA121
EV / EBIT-225
Revenue, mln42,219
EV / Revenue7.04
Quote Details
Last
34.35
Change
1.11 (3.34%)
Open
34.42
Volume
27,548
Turnover
946,274
Average Volume
6,997.9
Financial Ratios
Pre-Tax Profit Margin-6
Current Ratio1.27
Price / Book16.37
Price / Free Cash Flow15.08
Debt / Equity2.22
Price / Sales6.39
PEG Ratio3.25
Financial Strength
Altman Z-Score3.77
Piotroski F-Score
5
/ 9
Beneish M-Score-4.11
Price to Intrinsic Value1.97
Shiller PE Ratio40.85
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
9.36% |
99
/ 100
 |
| 1 Month |
14.27% |
95
/ 100
|
| 2 Months |
30.4% |
97
/ 100
|
| 6 Months |
29.86% |
94
/ 100
 |
|
| |
